SCHEMBL9528025

SCHEMBL9528025

[CH2]n1nc(CCCCC)nc1CCCCC

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
KCNH2 Q12809 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
GPR84 Q9NQS5 1/20 0.33
ATM Q13315 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 3/20 0.33
HTT P42858 1/20 0.33
LMNA P02545 2/20 0.32
TSHR P16473 1/20 0.32
HPGD P15428 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
AGTR1 P30556 1/20 0.31
AGTR2 P50052 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9528033 0.78 SIRT1 (0.44) XDHSIRT1KCNH2CNR1CNR2
SCHEMBL8105628 0.77 PDE4A (0.42) TLR7ADORA3ADORA2AADORA1
SCHEMBL13585976 0.76 AGTR1 (0.39) SIRT1CYP1A2CYP2C9CYP2C19AGTR1
SCHEMBL8259928 0.72 SIRT1 (0.49) XDHSIRT1SMN1; SMN2ALDH1A1HTT
SCHEMBL14394352 0.71 AGTR1 (0.41) SIRT1AGTR1AGTR2
SCHEMBL92739 0.69 KCNH2 (0.46) KCNH2GPR84SMN1; SMN2ALDH1A1TSHR
SCHEMBL13714538 0.68 SIRT1 (0.36) XDHSIRT1CNR1CNR2ALDH1A1
SCHEMBL7711334 0.67 KCNH2 (0.50) KCNH2GPR84SMN1; SMN2ALDH1A1LMNA
SCHEMBL31054446 0.67 KCNH2 (0.50) KCNH2GPR84SMN1; SMN2ALDH1A1LMNA
SCHEMBL29523323 0.67 KCNH2 (0.50) KCNH2GPR84SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed